Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs.
Location: United States, Virginia, Manassas
Employees: 1-10
Total raised: $1.8M
Investors 2
| Date | Name | Website |
| - | E14 Fund | e14.vc |
| - | GS Futures | gsfutures.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.06.2022 | Pre-Seed | $1.8M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 06.09.2023 | TechCrunch Disrupt 2023 Startup Battlefield 200: Health tech... | You’re just a couple weeks away from meeting the Startup Battlefield 200 companies in person at Tech... | techcrunch... |
| 06.06.2022 | Capra Biosciences Raises $1.8M in Pre-Seed Funding | Capra Biosciences co-founders Elizabeth Onderko, CEO, and Andrew Magyar, chief technology officer, p... | finsmes.co... |
| 17.03.2021 | From improving cancer treatments to saving the bees, these a... | Ultra-precise cancer therapies! Human-like hair grown from plants! A way to potentially save the bee... | techcrunch... |
| - | Capra Biosciences | “We use biology to make high performance renewable chemicals affordable and sustainable. We are revo... | fastfounde... |